{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:35:57Z","timestamp":1787070957024,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context:<\/jats:title>\n                    <jats:p>Splenic B-cell lymphoma\/leukemia with prominent nucleoli (SBLPN) aka hairy cell leukemia variant (HCL-v) is a rare B-cell chronic lymphoproliferative disorder. The main diagnostic challenge is to differentiate SBLPN from Classical hairy cell leukemia (HCL-c), as the former faces inferior responses to therapies and a poor prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The aim is to discuss the clinic-hematological and immunophenotyping findings of three cases of SBLPN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>This is a retrospective observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Material:<\/jats:title>\n                    <jats:p>From the year 2011 to 2021, flow cytometry of all the cases with HCL diagnosis was reviewed, and three cases with negative or dim CD25 and hematological presentation matching with SBLPN were picked up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>Descriptive statistics is used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      All the cases were male. The age ranges from 43 to 64 years. Median hemoglobin concentration, total leucocyte count, and platelet count were 8.6 g\/dL, 6.9 \u00d7 10\n                      <jats:sup>9<\/jats:sup>\n                      \/L, and 53 \u00d7 10\n                      <jats:sup>9<\/jats:sup>\n                      \/L, respectively. The atypical cells were medium to large. All three showed prominent nucleoli. Bone marrow biopsies showed an interstitial pattern of infiltration in all the cases. The hairy cells were positive for CD20, CD11c, and CD103. CD25 was dim positive in one case. Annexin A1 was negative in all three cases. BRAF V600E mutation analysis was done in one case and turned out negative for the mutation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>SBLPN is a rare entity, usually on-flow cytometry CD25 negative. However, in dim CD25-positive cases, BRAFV600E mutational analysis helps in discerning SBLPN diagnosis and differentiating it from HCL-c.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1931_22","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T15:01:04Z","timestamp":1711810864000},"page":"315-320","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Splenic B-cell lymphoma\/leukemia with prominent nucleoli: A three-case series of the newly named old entity and review of literature"],"prefix":"10.4103","volume":"20","author":[{"given":"Varnika","family":"Rai","sequence":"first","affiliation":[{"name":"Onco-Pathology Department, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Saha","sequence":"additional","affiliation":[{"name":"Onco-Pathology Department, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Gondha","sequence":"additional","affiliation":[{"name":"Onco-Pathology Department, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poornima","family":"Manimaran","sequence":"additional","affiliation":[{"name":"Onco-Pathology Department, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Sawhney","sequence":"additional","affiliation":[{"name":"Onco-Pathology Department, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"key":"R1-20260507","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.V76.1.157.157","article-title":"A variant form of hairy cell leukemia resistant to alpha-interferon:Clinical and phenotypic characteristics of 17 patients","volume":"76","author":"Sainati","year":"1990","journal-title":"Blood"},{"key":"R2-20260507","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.leu.2401999","article-title":"The natural history and clinico-pathological features of the variant form of hairy cell leukemia","volume":"15","author":"Matutes","year":"2001","journal-title":"Leukemia"},{"key":"R3-20260507","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/ccr3.2176","article-title":"Variant form of hairy cell leukemia","volume":"7","author":"Wiber","year":"2019","journal-title":"Clin Case Rep"},{"key":"R4-20260507","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours:Lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"R5-20260507","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R6-20260507","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3109\/10428194.2011.575488","article-title":"Hairy cell leukemia, blastic type:Description of spleen morphology and immunophenotype of a distinctive case","volume":"52","author":"Kanellis","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"R7-20260507","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1521-6926(02)00086-5","article-title":"The variant form of hairy-cell leukaemia","volume":"16","author":"Matutes","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"R8-20260507","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.blre.2014.06.003","article-title":"Hairy cell leukemia:Update on molecular profiling and therapeutic advances","volume":"28","author":"Grever","year":"2014","journal-title":"Blood Rev"},{"key":"R9-20260507","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.leukres.2012.11.021","article-title":"Distinguishing hairy cell leukemia variant from hairy cell leukemia:Development and validation of diagnostic criteria","volume":"37","author":"Shao","year":"2013","journal-title":"Leuk Res"},{"key":"R10-20260507","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2141.2012.09163.x","article-title":"The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma","volume":"158","author":"Hockley","year":"2012","journal-title":"Br J Haematol"},{"key":"R11-20260507","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/s41379-018-0093-8","article-title":"Clinicopathologic and molecular features in hairy cell leukemia-variant:Single institutional experience","volume":"31","author":"Angelova","year":"2018","journal-title":"Mod Pathol"},{"key":"R12-20260507","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/ajh.24580","article-title":"Refractory hairy cell leukemia- variant","volume":"92","author":"Hu","year":"2016","journal-title":"Am J Hematol"},{"key":"R13-20260507","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1309\/8QYTYQ1CLQMHQ9CL","article-title":"Hairy cell leukemia variant:Fact or fiction","volume":"123","author":"Cessna","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R14-20260507","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ctrv.2006.04.010","article-title":"Current treatment options in hairy cell leukemia and hairy cell leukemia variant","volume":"32","author":"Robak","year":"2006","journal-title":"Cancer Treat Rev"},{"issue":"(Suppl 1)","key":"R15-20260507","first-page":"57","article-title":"The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes","volume":"14","author":"Matutes","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"R16-20260507","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1182\/blood-2009-01-201731","article-title":"VH4-34+hairy cell leukemia, a new variant with poor prognosis despite standard therapy","volume":"114","author":"Arons","year":"2009","journal-title":"Blood"},{"key":"R17-20260507","first-page":"601","article-title":"Absence of cyclin D1 protein expression in splenic marginal zone lymphoma","volume":"11","author":"Savilo","year":"1998","journal-title":"Mod Pathol"},{"key":"R19-20260507","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0140-6736(04)16356-3","article-title":"Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1)","volume":"363","author":"Falini","year":"2004","journal-title":"Lancet"},{"key":"R20-20260507","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.beha.2015.09.002","article-title":"Hairy cell leukaemia-variant:Disease features and treatment","volume":"28","author":"Matutes","year":"2015","journal-title":"Best Pract Res Clin Haematol"},{"key":"R21-20260507","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/10428194.2011.565096","article-title":"Chemo-immunotherapy for hairy cell leukemia","volume":"52","author":"Ravandi","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"R22-20260507","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2147\/OTT.S242247","article-title":"Current and emerging therapeutic options for hairy cell leukemia variant","volume":"14","author":"Liu","year":"2021","journal-title":"Onco Targets Ther"},{"key":"R23-20260507","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1096-8652(199610)53:2<121::AID-AJH11>3.0.CO;2-I","article-title":"Atypical prolymphocytic variant of hairy-cell leukemia:Case report and review of the literature","volume":"53","author":"Dunphy","year":"1996","journal-title":"Am J Hematol"},{"key":"R24-20260507","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/1060028019836775","article-title":"No loose ends:A review of the pharmacotherapy of hairy cell and hairy cell leukemia variant","volume":"53","author":"King","year":"2019","journal-title":"Ann Pharmacother"},{"key":"R25-20260507","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/10428194.2016.1185786","article-title":"Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant","volume":"58","author":"Mason","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"R26-20260507","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/bjh.17055","article-title":"Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL-V)","volume":"191","author":"Parry-Jones","year":"2020","journal-title":"Br J Haematol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1931_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:39:34Z","timestamp":1787067574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1931_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1931_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]},"assertion":[{"value":"2022-09-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}